Everything we've seen

1. ·Sep 13, 10:15 AMstreamworld_news

   GE HealthCare nears approximately $1 billion acquisition of Sofie Biosciences.

   Sectors: Health Care · Tickers: GEHC

2. ?Sep 11, 6:00 PMdecisionconsidered

   Agent 9 — Bear Equity — considered

   Stage 4: close $63.93 < MA150 $69.23 (-7.7%), MA falling, 28.8% off 52w high, vol 0.88× avg

3. ?Sep 10, 6:03 PMdecisionconsidered

   Agent 1 — Immutable — considered

   Stage 4: close $64.24 < MA150 $69.36 (-7.4%), MA falling, 28.4% off 52w high, vol 1.18× avg

4. ?Sep 10, 6:03 PMdecisionconsidered

   Agent 9 — Bear Equity — entry

   [not executed — reserve_floor_or_cash] Stage 4: close $64.24 < MA150 $69.36 (-7.4%), MA falling, 28.4% off 52w high, vol 1.18× avg

5. ?Sep 10, 6:03 PMdecisionconsidered

   Agent 2 — Adaptive — considered

   Stage 4: close $64.24 < MA150 $69.36 (-7.4%), MA falling, 28.4% off 52w high, vol 1.18× avg

6. ?Sep 9, 6:03 PMdecisionconsidered

   Agent 2 — Adaptive — considered

   Stage 4: close $65.17 < MA150 $69.48 (-6.2%), MA falling, 27.4% off 52w high, vol 1.12× avg

7. ?Sep 9, 6:03 PMdecisionconsidered

   Agent 9 — Bear Equity — considered

   Stage 4: close $65.17 < MA150 $69.48 (-6.2%), MA falling, 27.4% off 52w high, vol 1.12× avg

8. ?Sep 8, 6:03 PMdecisionconsidered

   Agent 9 — Bear Equity — considered

   Stage 4: close $66.78 < MA150 $69.57 (-4.0%), MA falling, 25.6% off 52w high, vol 1.19× avg

9. ?Sep 4, 6:01 PMdecisionconsidered

   Agent 9 — Bear Equity — considered

   Stage 4: close $68.85 < MA150 $69.66 (-1.2%), MA falling, 23.3% off 52w high, vol 0.89× avg

10. ?Sep 3, 6:03 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $69.71 < MA150 $69.73 (-0.0%), MA falling, 22.3% off 52w high, vol 0.82× avg

11. ?Aug 6, 6:00 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $70.34 < MA150 $71.10 (-1.1%), MA falling, 21.6% off 52w high, vol 1.09× avg

12. ?Aug 5, 6:01 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $70.25 < MA150 $71.19 (-1.3%), MA falling, 21.7% off 52w high, vol 0.34× avg

13. ?Aug 4, 6:01 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $70.25 < MA150 $71.27 (-1.4%), MA falling, 21.7% off 52w high, vol 0.41× avg

14. ?Aug 3, 6:00 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $69.71 < MA150 $71.36 (-2.3%), MA falling, 22.3% off 52w high, vol 0.55× avg

15. ?Jul 31, 6:00 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $68.02 < MA150 $71.45 (-4.8%), MA falling, 24.2% off 52w high, vol 0.81× avg

16. ?Jul 30, 6:00 PMdecisionconsidered

    Agent 9 — Bear Equity — considered

    Stage 4: close $69.98 < MA150 $71.56 (-2.2%), MA falling, 22.0% off 52w high, vol 1.96× avg

17. ❖Jul 29, 3:05 PMnewsvia finnhub

    These S&P500 stocks are moving in today's session

    Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Wednesday.

18. ❖Jul 29, 1:32 PMnewsvia finnhub

    GE HealthCare Technologies Inc. Q2 2026 Earnings Call Summary

    Moby summary of GE HealthCare Technologies Inc.'s Q2 2026 earnings call

19. ❖Jul 29, 1:28 PMnewsvia finnhub

    Stock Market Today: Dow Sinks As Fed Rate Decision, Warsh Comments Loom; KLA Tumbles (Live Coverage)

    Stock Market Today: The Dow Jones index drops Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. KLA stock is hit.

20. ❖Jul 29, 1:05 PMnewsvia finnhub

    Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.

    In today's session, there are S&P500 stocks with remarkable trading volume. Explore the stocks exhibiting unusual volume in Wednesday's session.

21. ❖Jul 29, 12:35 PMnewsvia finnhub

    Uncover the latest developments among S&P500 stocks in today's session.

    Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.

22. ❖Jul 29, 12:09 PMnewsvia finnhub

    Here's Why GE Healthcare Shares Popped Higher Today

    Cost increases have hit the company in 2026, but today's earnings report provides evidence of an oncoming improvement.

23. ❖Jul 29, 11:42 AMnewsvia finnhub

    GEHC Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market

    GE HealthCare beats second-quarter estimates as revenues rise 5.7%, orders climb 11.1% and backlog hits a record $23.9 billion.

24. ❖Jul 29, 11:20 AMnewsvia finnhub

    Stock Market Today: Dow Dives 800 Points As Fed Rate Call Looms; GE HealthCare Soars (Live Coverage)

    Stock Market Today: The Dow Jones index drops Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sells off.

25. ❖Jul 29, 11:08 AMnewsvia finnhub

    Vertiv, SoFi, GE HealthCare, Micron, SK Hynix, Garmin, and More Stocks That Explain Today’s Market

    FEATURE Stocks were tumbling Wednesday ahead of the Federal Reserve’s decision on interest rates. Garmin was a rare bright spot, surging 16% to lead the The Swiss technology company best known for its navigation hardware and fitness trackers lifted its full-year targets following a surge in demand for the second quarter.

26. ❖Jul 29, 11:05 AMnewsvia finnhub

    S&P 500 Stocks: GEHC Revives, Humana Fades On Earnings

    GE HealthCare Technologies ran at the top of the S&P 500 Wednesday morning, while Humana was among major laggards after both companies posted better-than-expected Q2 earnings signaling a return to profit growth. GEHC broke above its recent trading range that followed its dive on Q1 results. Wednesday's stock action was pretty much the reversal of what we've seen this year for GEHC and HUM, with medical equipment stocks among the market's worst-performing industry groups and managed-care stocks ranked in the top tier.

27. ❖Jul 29, 11:04 AMnewsvia finnhub

    GE HealthCare Technologies Q2 Earnings Call Highlights

    GE HealthCare Technologies (NASDAQ:GEHC) reported second-quarter results marked by strong order growth, a record backlog and continued momentum in its Advanced Imaging Solutions and Pharmaceutical Diagnostics businesses, while Patient Care Solutions remained pressured by operational fulfillment issu

28. ❖Jul 29, 10:35 AMnewsvia finnhub

    Wednesday's session: gap up and gap down stock in the S&P500 index

    Curious about the market action on Wednesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

29. ❖Jul 29, 8:43 AMnewsvia finnhub

    GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call Transcript

    GE HealthCare Technologies Inc. (GEHC) Q2 2026 Earnings Call July 29, 2026 8:30 AM EDTCompany ParticipantsCarolynne Borders - Chief Investor Relations...

30. ❖Jul 29, 8:35 AMnewsvia finnhub

    Get insights into the top movers in the S&P500 index of Wednesday's pre-market session.

    The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.

31. ❖Jul 29, 8:33 AMnewsvia finnhub

    GE HealthCare Beats Second-Quarter Expectations as Record Orders Drive Growth

    GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported stronger-than-expected second-quarter results on Wednesday, with record order growth and revenue exceeding Wall Street forecasts, sending shares about 9% higher in pre-market trading.

32. ❖Jul 29, 7:59 AMnewsvia finnhub

    Stocks Mostly Up Pre-Bell Ahead of Fed Rate Decision, Big Tech Earnings

    The main US stock measures were mostly trending higher in Wednesday's premarket activity as traders

33. ❖Jul 29, 7:34 AMnewsvia finnhub

    GE HealthCare Hits Record Backlog, Stock Jumps

    GE HealthCare (GEHC) stock surged after Q2 earnings beat estimates, driven by strong imaging and diagnostics growth.

34. ❖Jul 29, 7:30 AMnewsvia finnhub

    GE HealthCare Technologies (GEHC) Beats Q2 Earnings and Revenue Estimates

    GE HealthCare (GEHC) delivered earnings and revenue surprises of +8.65% and +0.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

35. ❖Jul 29, 7:29 AMnewsvia finnhub

    GE HealthCare Stock Soars After Earnings. Here’s What Drove the Profit Gains.

    GE HealthCare reports earnings per share of $1.13 from sales of $5.3 billion. Wall Street was looking for $1.04 a share and $5.3 billion, respectively.

36. ❖Jul 29, 7:25 AMnewsvia finnhub

    GE HealthCare (NASDAQ:GEHC) Surges on Q2 Earnings Beat

    GE HealthCare Q2 EPS $1.13 beats estimates, revenue in-line at $5.295B. Record orders drive stock 11% higher pre-market. Guidance reaffirmed.

37. ❖Jul 29, 7:03 AMnewsvia finnhub

    GE HealthCare beats estimates as orders surge to record high

    Investing.com -- GE HealthCare Technologies Inc. (NASDAQ:GEHC) reported second-quarter results before the open on Wednesday, exceeding Wall Street expectations.

38. ❖Jul 29, 6:39 AMnewsvia finnhub

    GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars

    Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 5.8% year on year to $5.30 billion. Its non-GAAP profit of $1.13 per share was 9.1% above analysts’ consensus estimates.

39. ❖Jul 29, 6:20 AMnewsvia finnhub

    GE HealthCare reports second quarter 2026 financial results

    CHICAGO, July 29, 2026--GE HealthCare (Nasdaq: GEHC) today reported financial results for the second quarter ended June 30, 2026.

40. ❖Jul 29, 6:03 AMnewsvia finnhub

    Ford, Garmin, GE HealthCare, Clean Harbors And Other Big Stocks Moving Higher On Wednesday

    U.S. stocks fell with the Dow Jones down 600 points. Ford&#39;s Q2 EPS and FY26 guidance boosted shares by 7.4%. Verra, Huron, Manhattan Assoc. also saw gains.

41. ❖Jul 29, 4:05 AMnewsvia finnhub

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

    Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday&#39;s pre-market session. The company&#39;s market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares moved

42. ❖Jul 29, 3:36 AMnewsvia finnhub

    Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more

    These are the stocks posting the largest moves premarket.

43. ❖Jul 29, 2:21 AMnewsvia finnhub

    GE HealthCare Techs Affirms FY2026 Adj EPS Guidance of $4.80-$5.00 vs $4.87 Est

    GE HealthCare Techs (NASDAQ:GEHC) affirms FY2026 Adj EPS guidance from $4.80-$5.00 to $4.80-$5.00 vs $4.87 analyst estimate..

44. ❖Jul 29, 2:20 AMnewsvia finnhub

    GE HealthCare Techs Q2 Adj. EPS $1.13 Beats $1.03 Estimate, Sales $5.295B Beat $5.264B Estimate

    GE HealthCare Techs (NASDAQ:GEHC) reported quarterly earnings of $1.13 per share which beat the analyst consensus estimate of $1.03 by 9.71 percent. This is a 6.6 percent increase over earnings of $1.06 per share from

45. ▣Jul 28, 8:00 PMjournalstop

    Agent 9 — Bear Equity closed short 159 @ $71.94 (-$1,495.40)

    intraday stop sweep

46. ❖Jul 28, 3:30 PMnewsvia finnhub

    Global Digital Transformation in Healthcare Market Size/Share Worth USD 270.9 Billion by 2035 at a 14.13% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

    [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Digital Transformation in Healthcare Market size & share revenue was valued at approximately USD 72.3 Billion in 2025 and is expected to reach USD 81.7 Billion in 2026 and is expected to reach around USD 270.9 Billion by 2035, at a CAGR of 14.13% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Oracle Hea

47. ❖Jul 28, 9:15 AMnewsvia finnhub

    What Analyst Projections for Key Metrics Reveal About GE HealthCare (GEHC) Q2 Earnings

    Get a deeper insight into the potential performance of GE HealthCare (GEHC) for the quarter ended June 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

48. ❖Jul 28, 6:21 AMnewsvia finnhub

    GE HealthCare (GEHC) To Report Earnings Tomorrow: Here Is What To Expect

    Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings this Wednesday before market open. Here’s what investors should know.

49. ❖Jul 26, 7:58 AMnewsvia finnhub

    GE HealthCare Technologies Inc. (GEHC) Beats Q2 Expectations, Reaffirms 2026 Outlook Despite CFO Transition

    GE HealthCare Technologies Inc. (NASDAQ:GEHC) posted preliminary fiscal second-quarter 2026 financial results on July 23, reporting accelerated top-line growth and earnings that topped management’s prior expectations. The announcement was paired with news that Chief Financial Officer James (Jay) Saccaro will step down on August 14 to take an expanded role outside the medical technology industry. […]

50. ?Jul 24, 6:01 PMdecisionconsidered

    Agent 1 — Immutable — considered

    Stage 4: close $60.59 < MA150 $71.99 (-15.8%), MA falling, 32.5% off 52w high, vol 2.69× avg

51. ?Jul 24, 6:00 PMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $60.59 < MA150 $71.99 (-15.8%), MA falling, 32.5% off 52w high, vol 2.69× avg

52. ❖Jul 24, 11:24 AMnewsvia finnhub

    Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?

    GE HealthCare heads into Q2 earnings season with solid revenue drivers, but inflation and tariff costs may keep margins under pressure before an expected second-half recovery.

53. ❖Jul 23, 4:15 PMnewsvia finnhub

    GE HealthCare announces CFO transition; reports preliminary second quarter 2026 financial results and reaffirms guidance reflecting business momentum

    CHICAGO, July 23, 2026--GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has appointed George Newcomb, currently Controller and Chief Accounting Officer, as interim Chief Financial Officer. Mr. Saccaro will remain with the Company through August 14, 2026, and work together with Mr. Newcomb to ensure a smooth transition. GE HealthCare has commenced

54. ❖Jul 23, 12:28 PMnewsvia finnhub

    GE HealthCare Appoints Chief Accounting Officer George Newcomb Interim CFO, Succeeding Jay Saccaro; Co. Anticipates Reporting 5.7% Revenue Growth For Q2, Reiterates FY26 Outlook

    GE HealthCare (Nasdaq: GEHC) today announced that Jay Saccaro will step down as Vice President and Chief Financial Officer for an expanded role outside of the medical technology industry. The Company has appointed

55. ❖Jul 21, 10:48 AMnewsvia finnhub

    GEHC Launches MIM Anyware for Secure Remote Imaging Collaboration

    GE HealthCare's MIM Anyware offers secure browser-based imaging access to streamline workflows, collaboration and clinical decision-making.

56. ❖Jul 20, 8:00 AMnewsvia finnhub

    GE HealthCare introduces MIM Anyware to extend remote access to imaging data and optimize clinical collaboration

    CHICAGO, July 20, 2026--GE HealthCare (Nasdaq: GEHC) today announced the introduction of MIM Anyware™, a remote access platform that provides secure, healthcare system-controlled access to imaging data through a web browser without requiring local software installation. By enabling authorized users to access MIM software applications from virtually any location, MIM Anyware is designed to support collaboration across departments and clinical decision-making.

57. ❖Jul 17, 3:05 PMnewsvia finnhub

    Discover which S&P500 stocks are making waves on Friday.

    Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session.

58. ❖Jul 17, 12:35 PMnewsvia finnhub

    These S&P500 stocks are moving in today's session

    Curious about the S&P500 stocks that are in motion on Friday? Join us as we explore the top movers within the S&P500 index during today's session.

59. ❖Jul 17, 10:55 AMnewsvia finnhub

    GE Aerospace Faces a Prove-It Moment in Q2 Earnings

    GE Aerospace shares fell despite Q2 2026 earnings beats and raised full-year guidance, as investors weigh a rich 46x forward earnings valuation against a $210 billion backlog.

60. ❖Jul 17, 10:26 AMnewsvia finnhub

    GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health

    GE HealthCare's shares rise about 4% after unveiling a $500M, 10-year alliance to deploy 1,300 technologies across Catholic Health.

61. ❖Jul 16, 10:10 AMnewsvia finnhub

    UBS Maintains Neutral on GE HealthCare Techs, Lowers Price Target to $67

    UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and lowers the price target from $69 to $67.

62. ❖Jul 16, 7:15 AMnewsvia finnhub

    GE HealthCare (GEHC) Lands $500 Million Catholic Health Deal For Imaging And AI

    GE HealthCare Technologies and Catholic Health have entered a roughly $500m Care Alliance spanning 10 years. The agreement covers modernization of imaging, cardiology, and other specialty services across more than 40 Catholic Health sites. The partnership includes advanced imaging systems, AI-enabled tools, software, cloud solutions, and asset management services. GE HealthCare Technologies (NasdaqGS:GEHC), trading around $63.2, has seen its share price down 23.7% year to date and down...

63. ❖Jul 16, 5:00 AMnewsvia finnhub

    Catholic Health and GE HealthCare partner to expand patient access across Long Island

    ROCKVILLE CENTRE, N.Y., July 16, 2026--Catholic Health, an integrated health system located on Long Island, NY, and GE HealthCare (Nasdaq: GEHC) announced today a 10-year strategic partnership, known as a Care Alliance, valued at approximately $500 million, to help expand access to advanced imaging, precision diagnostics and AI-enabled technology across Catholic Health in support of innovative, compassionate and patient-centered care. This will be one of the largest Care Alliances between GE Hea

64. ❖Jul 16, 1:34 AMnewsvia finnhub

    Catholic Health And GE HealthCare Announce $500M, 10-Year Care Alliance To Expand Patient Access Across Long Island

    More than 1,300 pieces of technology to be added across Catholic Health hospitals and ambulatory locations, expanding access to advanced imaging, diagnostics and specialized care closer to homeAI-powered technologies to

65. ❖Jul 16, 1:16 AMnewsvia finnhub

    GE HealthCare Technologies (GEHC) Following Mayo Clinic Trial Tie Up Faces A Fresh Valuation Test

    GE HealthCare Technologies (GEHC) is back in focus after a new research collaboration with Mayo Clinic on the MI-BET theranostics trial for advanced prostate cancer, highlighting its molecular imaging and radioligand therapy capabilities. See our latest analysis for GE HealthCare Technologies. At a recent share price of US$63.20, GE HealthCare Technologies has seen the share price fall 13.66% over the past 90 days and the 1-year total shareholder return decline 16.09%, as investors reacted to...

66. ?Jul 15, 6:01 PMdecisionconsidered

    Agent 1 — Immutable — considered

    Stage 4: close $63.22 < MA150 $72.98 (-13.4%), MA falling, 29.6% off 52w high, vol 1.87× avg

67. ?Jul 15, 6:01 PMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $63.22 < MA150 $72.98 (-13.4%), MA falling, 29.6% off 52w high, vol 1.87× avg

68. ❖Jul 15, 11:12 AMnewsvia finnhub

    Can GE HealthCare (GEHC) Turn Theranostic Partnerships Into a Durable Advanced Diagnostics Edge?

    GE HealthCare and Mayo Clinic recently launched the MI-BET research collaboration, using StarGuide SPECT/CT and biomarker data to personalize radioligand therapy for advanced prostate cancer at Mayo Clinic’s Rochester campus. An especially interesting element is the study’s use of imaging- and biomarker-driven pause decisions in treatment, potentially reshaping how clinicians tailor theranostic care. We’ll now examine how this theranostics-focused Mayo Clinic collaboration could influence GE...

69. ?Jul 14, 6:02 PMdecisionconsidered

    Agent 2 — Adaptive — entry

    [not executed — reserve_floor_or_cash] Stage 4: close $61.66 < MA150 $73.13 (-15.7%), MA falling, 31.3% off 52w high, vol 2.56× avg

70. ?Jul 14, 6:01 PMdecisionconsidered

    Agent 1 — Immutable — considered

    Stage 4: close $61.66 < MA150 $73.13 (-15.7%), MA falling, 31.3% off 52w high, vol 2.56× avg

71. ❖Jul 14, 3:05 PMnewsvia finnhub

    Discover which S&P500 stocks are making waves on Tuesday.

    Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the latest happenings in today's session.

72. ❖Jul 14, 12:35 PMnewsvia finnhub

    These S&P500 stocks are moving in today's session

    Uncover the latest developments among S&P500 stocks in today's session. Stay tuned to the S&P500 index's top gainers and losers on Tuesday.

73. ❖Jul 14, 10:49 AMnewsvia finnhub

    Do Options Traders Know Something About GE HealthCare Stock We Don't?

    Investors need to pay close attention to GEHC stock based on the movements in the options market lately.

74. ?Jun 17, 6:00 PMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $61.15 < MA150 $74.55 (-18.0%), MA falling, 31.9% off 52w high, vol 1.68× avg

75. ?Jun 3, 10:44 AMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $61.39 < MA150 $75.28 (-18.5%), MA falling, 31.6% off 52w high, vol 0.02× avg

76. ?May 18, 12:18 PMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $49.40 < MA150 $60.94 (-18.9%), MA falling, 31.2% off 52w high, vol 0.04× avg

77. ?May 18, 12:18 PMdecisionconsidered

    Agent 1 — Immutable — considered

    Stage 4: close $49.40 < MA150 $60.94 (-18.9%), MA falling, 31.2% off 52w high, vol 0.04× avg

78. ✓May 12, 2:09 PMdecisionacted

    Agent 9 — Bear Equity — entry

    Stage 4: close $62.53 < MA150 $76.49 (-18.2%), MA falling, 30.3% off 52w high, vol 0.04× avg

79. ?May 12, 12:04 PMdecisionconsidered

    Agent 2 — Adaptive — considered

    Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg

80. ?May 12, 12:04 PMdecisionconsidered

    Agent 1 — Immutable — considered

    Stage 4: close $61.94 < MA150 $76.49 (-19.0%), MA falling, 31.0% off 52w high, vol 0.02× avg

81. ▢May 11, 8:00 PMjournal

    Agent 9 — Bear Equity opened short 159 @ $62.53